JAZZ PHA reported $-19648000 in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbvie ABBV:US USD 3.95B 3.03B
ALKERMES ALKS:US USD -63974000 33.84M
Amarin AMRN:US USD -5140000 64.82M
Cara Therapeutics CARA:US USD -23180000 18.97M
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Halozyme Therapeutics HALO:US USD 61.63M 38.95M
Hikma Pharmaceutical HIK:LN USD 173M 0
Horizon Pharma HZNP:US USD 135.84M 74.86M
Lannett LCI:US USD -28019000 65.28M
Mckesson MCK:US USD 926M 158M
Merk MRK:US USD 3.25B 696M
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Pacira Pharmaceuticals PCRX:US USD -693000 20.57M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Pfizer PFE:US USD 8.61B 1.3B
Revance Therapeutics RVNC:US USD -84693000 23.26M
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
Xeris Pharmaceuticals Inc XERS:US USD -21831000 4.35M
Zoetis ZTS:US USD 529M 0